Echomay2015

Page 1

May 2015 Vol. 17 Issue 5

ECHO

THE EMPLOYEE NEWSLETTER OF HOSPITAL FOR SPECIAL SURGERY

Lionel B. Ivashkiv, M.D. Appointed Chief Scientific Officer esearch is a cornerstone of our vision

Leadership in Research SS scientists

R

H

than 200 scientists and staff work to identify

professional organizations

causes of musculoskeletal and autoimmune

throughout the years. One

diseases and develop effective approaches for

of these is the Orthopedic

diagnoses, treatment and long-term benefits to

Research Society (ORS),

patients. Our scientists’ and physicians’ research

an organization whose

continues to shape the future of musculoskeletal

purpose is to promote,

and mission – it is critical to enhanced

have held

patient care and HSS’ impact on the

research

fields of orthopedics and rheumatology. More

leadership positions in

Dr. Bostrom and Dr. Goldring at the ORS Annual Meeting

medicine and the foundation for better treatments

support, develop and encourage research in ortho-

and patient care.

paedics and musculoskeletal disease and related

HSS recently announced that Lionel B. Ivashkiv,

disciplines and to provide a forum for dissemination of

M.D., premier scientist in autoimmune, inflammatory

knowledge in the fields. Five HSS scientists have been

and musculoskeletal diseases, would serve as the

president of this prestigious organization dedicated to Dr. Goldring (left) and Dr. Ivashkiv

the advancement of orthopaedic research.

the David H. Koch Chair in Arthritis and Tissue

enhancement of HSS’ position as a leader in

The most recent president inaugurated is Mathias

Degeneration and associate chief scientific officer,

musculoskeletal and autoimmune disease research.

P. Bostrom, M.D., senior clinician scientist, who

Dr. Ivashkiv succeeds Steven R. Goldring, M.D.,

“What’s unique about HSS is the team-based

transitioned into the role at a ceremony at the ORS

who has served in the role since 2006. Dr. Ivashkiv

approach to research and the linkage between

Annual Meeting that took place following the AAOS

assumed his new role on June 1 and this also marked

basic science and clinical research,” he said.

in March. Dr. Bostrom took over from Mary Goldring,

his 23rd anniversary at HSS.

“We are committed to asking meaningful scientific

Ph.D., senior scientist and co-director of the Tissue

questions and then figuring out a way to apply

Engineering Regeneration and Repair Program, who

advances in knowledge to impact patient care.”

was president during the prior year.

“During an exceptional tenure, Dr. Goldring has

The Research Division experienced unprecedented

A major aspect of the president’s leadership role is

fostered a creative and productive scientific

growth under Dr. Goldring’s leadership in the past

to head the ORS Board of Directors, which provides

environment, attracted new scientists and built

nine years. Some highlights include:

governance and direction; ensures that the mission of

the Research Division into the world-leader in

• HSS became an NIH Network Partner for

the ORS stays on course; approves activities and new

Hospital’s third chief scientific officer. Currently

Dr. Ivashkiv will build on a history of research and the infrastructure developed by Dr. Goldring.

musculoskeletal science it is today,” said

Rheumatoid Arthritis and Lupus

initiatives of the committees; recommends changes to

Lou Shapiro, president and CEO. “We look

The National Institutes of Health (NIH) awarded

the Bylaws; oversees the ORS Annual Meeting; formu-

forward to working with Dr. Ivashkiv to continue

grants to 11 research groups across the United

lates the strategic plan; and represents its members.

building and enhancing our Research Division.”

States to establish the Accelerating Medicines

“I’m honored to take on this role with the ORS and

“Dr. Ivashkiv’s career as a scientist includes major

Partnership in Rheumatoid Arthritis and Lupus

lead this amazing organization as we continue

contributions to the understanding of inflammatory

(AMP RA/Lupus) Network. HSS was selected as

working together to advance musculoskeletal research

mechanisms in autoimmune and musculoskeletal

a Research Site with Drs. Vivian Bykerk, Lionel

worldwide,” said Dr. Bostrom. “We are embarking on

disorders,” said Todd J. Albert, M.D., surgeon-in-chief

Ivashkiv, and Alessandra B. Pernis from the

the launch of a new strategic plan and I’m excited

and medical director. “He has outstanding natural

Research Division and Drs. Figgie, Sculco, Marx

about moving forward.” With the transition of

leadership skills and has earned the respect of his

and Hotchkiss from the Orthopaedic department

leadership from Dr. Goldring to Dr. Bostrom, the

colleagues both here at HSS and abroad which makes

leading the research initiative.

previous five-year strategic plan was concluded.

him ideally suited to lead our Research Division.”

• Creation of the David Z. Rosensweig Genomics

The new plan will focus on areas of funding, strategic partnerships, diversity and professional

“I am honored to work even more closely with

Research Center

colleagues who are committed to building on

With a $5.6 million grant from the Tow Foundation,

development, and adaptation to change. “Our new

HSS’ tradition of interdisciplinary translational

HSS created The David Z. Rosensweig Genomics

plan builds on the strong foundation put in place over

research,” said Dr. Ivashkiv. “Together we will

Research Center, under the direction of Dr.

CONTINUED on page 2

advance the Hospital’s research mission to

Ivashkiv. The goals are to define the regulation

translate breakthrough findings into new ways of

of genes associated with autoimmune and

treating and preventing serious orthopedic and

inflammatory diseases, and to develop more

rheumatic conditions.”

effective therapies for rheumatoid arthritis and

In this new role, Dr. Ivashkiv will work to develop and execute strategic plans to continue the

systemic lupus erythematosus.

CONTINUED on page 2

Inside

2 3

At HSS, It’s Safety First Epic: One patient. One record. One HSS.


Turn static files into dynamic content formats.

Create a flipbook
Issuu converts static files into: digital portfolios, online yearbooks, online catalogs, digital photo albums and more. Sign up and create your flipbook.